Nursing Home News — Page 193

Respiratory care failures carry a particular weight in a post-acute setting.

Inspectors determined, however, that the potential for more than minimal harm existed.

Pain in nursing home residents can surface in ways that don't announce themselves.

The drug was tacrolimus, an immunosuppressant used to prevent the body from rejecting a transplanted organ.

One of those citations targeted something fundamental: whether the facility was actually building complete care plans for the people living there.

It belongs to the people who live there.

But the classification also carries a specific warning built into its definition: the potential for more than minimal harm existed.

When the facility's Director of Social Services started her job in January 2025, she inherited a notebook.

The violation was classified at Scope and Severity Level D, meaning it was isolated in scope and involved no documented actual harm.

The inspection, completed September 2, 2025, was triggered by a complaint.

That distinction matters less than it might sound.

That last citation sits under a regulatory category covering resident assessment and care planning.